Treatment outcomes in patients with proven/probable versus possible invasive mould disease in a phase III trial comparing isavuconazole versus voriconazole

Mycoses,Volume 0, Issue ja, -Not available-.

Source: Mycoses - July 23, 2018 Category: Research Authors: Johan Maertens , Dominik Selleslag , Werner J. Heinz , Mikael Saulay , Galia Rahav , Michael Giladi , Mickael Aoun , Laura Kovanda , Achim Kaufhold , Marc Engelhardt , Oliver A. Cornely , Raoul Herbrecht , Andrew J. Ullmann Source Type: research